DSM Sinochem Pharmaceuticals appoints Anurag Roy as its new Business Unit Director Asia Pacific, Middle East and Africa

DSM Sinochem Pharmaceuticals, the global leader in sustainable antibiotics, next generation statins and anti-fungals, has appointed Anurag Roy as its new Business Unit Director for Asia Pacific, Middle East and Africa.Hewill also be the Global Product Owner, New API.

Anurag is a seasoned chemical, pharmaceutical and life sciences industry professional, having acquired a wealth of business and product management experience during his 17 years of strategic, operational and financial leadership. He has an excellent track record in uniquely challenging global and indigenous business environments, specifically in forging strategic partnerships with innovators, driving organizational profit and establishing credibility. Anurag has previously held senior management positions at various companies, most recently as Vice President, Custom Pharmaceuticals Services, Dr. Reddy’s Laboratories (DRL). He also has experience of escalating business growth at three US-based companies, BASE-SAF, a chemical manufacturer; ORC International, a market research consultancy and Frost and Sullivan, the global growth consulting firm. His areas of expertise have, therefore, encompassed driving business, strategic marketing, and motivating cross functional global teams for peak performance, mergers, acquisitions and new ventures.

Anurag holds an MBA from Columbia Business School, New York, USA. He has authored several articles which have appeared in leading publications such as LA Times, Chemical Week, Modern Plastics, International Journal of Polymer Sciences, Economic Times & Business India. He has also presented scientific papers and has been a key spokesperson at several international conferences.

DSM Sinochem Pharmaceuticals (DSP) is the global leader in sustainable antibiotics, next generation statins and anti-fungals. DSP develops, produces and sells raw materials, intermediates, active pharmaceutical ingredients and drug products. Our employees worldwide work together to deliver cutting edge generics solutions that help to keep customers ahead of the competition.Headquartered in Singapore, the group has operations in China, India, Egypt, the Netherlands, Spain, the US and Mexico. DSP is a 50/50 Joint Venture of Royal DSM, a global science-based company active in health, nutrition and materials, and Sinochem Group, a Fortune 500 enterprise.